Ganglei Li
Impact in
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
- RNA Research and Splicing 3
- Gut microbiota and health 2
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Lanjuan Li (6 shared papers)Zhengyi Bao (6 shared papers)Xinyu Gu (5 shared papers)Chen Xue (7 shared papers)Qiuxian Zheng (3 shared papers)Yuanshuai Su (2 shared papers)Juan Lü (3 shared papers)Juan Lu (2 shared papers)
- Journals
- Frontiers in Cell and Developmental Biology (2 papers)Biomedicine & Pharmacotherapy (2 papers)Molecular Cancer (1 paper)Signal Transduction and Targeted Therapy (1 paper)Cell Metabolism (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Ganglei Li
18 papers receiving 1.2k citations
Ganglei Li's Hit Papers
Peers
Comparison fields: 5 of 117
- Biological Psychiatry 145
- Cancer Research 257
- Molecular Biology 661
- Behavioral Neuroscience 25
- Neurology 50
Countries citing papers authored by Ganglei Li
This map shows the geographic impact of Ganglei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ganglei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ganglei Li more than expected).
Fields of papers citing papers by Ganglei Li
This network shows the impact of papers produced by Ganglei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ganglei Li. The network helps show where Ganglei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Ganglei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Tryptophan metabolism in health and disease Hit paper breakdown → | 2023 | 580 |
| 2 | 2021 | 155 | |
| 3 | 2022 | 99 | |
| 4 | 2021 | 72 | |
| 5 | 2020 | 57 | |
| 6 | 2023 | 52 | |
| 7 | 2021 | 38 | |
| 8 | 2023 | 30 | |
| 9 | 2022 | 28 | |
| 10 | 2021 | 28 | |
| 11 | 2021 | 20 | |
| 12 | 2021 | 19 | |
| 13 | 2024 | 19 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 8 | |
| 17 | 2022 | 5 | |
| 18 | 2022 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2026 | 0 |
About Ganglei Li
Ganglei Li is a scholar working on Molecular Biology, Cancer Research, Neurology, Strategy and Management and Epidemiology, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (4 papers), Circular RNAs in diseases (3 papers), RNA Research and Splicing (3 papers), MicroRNA in disease regulation (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Gut microbiota and health (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Biological Psychiatry (145 citations), Cancer Research (257 citations), Molecular Biology (661 citations), Behavioral Neuroscience (25 citations) and Neurology (50 citations). Ganglei Li has collaborated with scholars based in China and United States. Frequent co-authors include Lanjuan Li, Zhengyi Bao, Xinyu Gu, Chen Xue, Qiuxian Zheng, Yuanshuai Su, Juan Lü, Juan Lu, Xue Chen and Qingfei Chu. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Biomedicine & Pharmacotherapy, Molecular Cancer, Signal Transduction and Targeted Therapy and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.